Target
MUC1
1 product, 1 indication
Indications
recurrent prostate cancer (1 products)
Loading...
1 drug
2 abstracts
Abstract
Phase I clinical trial of MUC1-targeted CAR-T cells with PD-1-knockout in the treatment of advanced breast cancer.Org: Guangzhou Anjie Biomedical Technology Co. Ltd, Sun Yat-sen Memorial Hospital, Sun Yat-sen University Cancer Center,
Abstract
Addition of the MUC-1 vaccine tecemotide to neoadjuvant systemic therapy for patients with early breast cancer: Survival results from the prospective randomized ABCSG 34 trial.Org: Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Austrian Breast and Colorectal Cancer Study Group, Wien, Austria, Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Vienna, Austria, Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria, Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria,
Drug
MUC1 vaccine